Target intelligence / Profile preview

RNA, U6 small nuclear 646, pseudogene (RNU6-646P)

Target
RNU6-646P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA)-derived pseudogene
01

Overview

RNA, U6 small nuclear 646, pseudogene (RNU6-646P) is a non-coding RNA gene locus classified as a pseudogene, meaning it is a non-functional derivative of the U6 small nuclear RNA gene[2][5]. U6 small nuclear RNA (snRNA) is a highly conserved component of spliceosomal complexes involved in pre-mRNA splicing in eukaryotes[1][3], but the pseudogene variant such as RNU6-646P does not encode functional snRNA and does not participate in spliceosome formation or cellular functions[2]. While a vast number of U6 snRNA pseudogenes are scattered throughout the genome and can contain sequence remnants of authentic U6 snRNA (sometimes with limited transcriptional capacity), they are not generally biologically active and are not recognized as drug targets or functional proteins[3][5]. Some pseudogenes in other gene families have regulatory roles in disease; however, RNU6-646P is not documented to act as a regulatory element, biomarker, or have interactions with drugs[6].

Other names
RNU6-646P
02

Mechanism of action

None known (since there are no interacting drugs and the pseudogene itself is not a target)

03

Biological functions

No direct biological function; pseudogenes are typically non-functional copies, though in rare cases pseudogenes can exert regulatory effects as transcripts by acting as competitive endogenous RNAs (ceRNAs) or influencing RNA metabolism (no evidence found for RNU6-646P specifically)
04

Disease associations

No direct role is reported for RNU6-646P in disease; most pseudogenes have no pathogenic or therapeutic role, although some pseudogenes are implicated in regulatory networks in cancer and other diseases; nothing found specific to RNU6-646P
05

Safety considerations

None known (pseudogenes do not generally present safety concerns as therapeutic targets)
06

Interacting drugs

None known (pseudogenes are not known to interact with drugs)
07

Biomarkers

None known (RNU6-646P is not used for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on RNA, U6 small nuclear 646, pseudogene (RNU6-646P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 646, pseudogene (RNU6-646P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call